Anavex Life Sciences, a small drug maker in New York City, has committed publicly to an ambitious roster of clinical trials for its lead pipeline product Anavex 2-73, including trials in Alzheimer’s, Parkinson’s, and other serious neurological diseases.
But does Anavex have clearance from regulators in the U.S. and Europe to enroll patients in those Anavex trials?
About the Author Reprints
Anavex Now is trying to gain access to this potentially life saving drug for ALL AMERICANS! Please follow Anavex Now on Facebook and help us get this miracle drug to market. Oral dosing, safe, healthy side effects(Sleep, etc..) PLEASE HELP US GET THIS AWESOME DRUG TO MARKET..
Maybe should have held this “insight and analysis” a bit longer: https://www.nasdaq.com/press-release/anavex-life-sciences-receives-approval-to-initiate-phase-2-clinical-trial-of-anavex273-for-the-20180709-00270